+91 9650760803 
Published: September 24, 2021 | Updated: July 30, 2026
Key Takeaways
- 01. Mechanism of Action:
The therapy uses Mesenchymal Stem Cells (MSCs) to reduce immune system overactivity, lower inflammation, and support tissue repair in SLE. - 02. Evidence of Benefits:
Early clinical and animal studies show MSC treatment led to reduced disease activity, improved organ function (kidney, liver, lung), and decreased auto-antibody levels in SLE patients. - 03. Experimental Status:
In India, the treatment remains experimental. There is no broad regulatory approval or large-scale trial data to establish standard protocols or long-term outcomes. - 04. Patient Selection Factors:
Success depends on disease stage, organ involvement, patient health, and type/source of stem cells used. Earlier intervention generally yields better responses. - 05. Treatment Access and Cost:
Stem cell programmes for lupus are available in Delhi/Noida, but costs, protocols, and centres vary. Patients should compare options carefully.
Overview
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system mistakenly attacks the body’s own healthy tissue instead of just foreign invaders like bacteria and viruses. It’s the most common form of lupus, and it can affect multiple organ systems at once — skin, joints, kidneys, lungs, blood, and the nervous system — which is why symptoms and severity vary widely from person to person.
SLE follows a relapsing-remitting pattern: periods of active disease (“flares”) alternate with periods of relative calm. It’s diagnosed more often in women than men, particularly during reproductive years, and having a family member with lupus or another autoimmune condition raises individual risk.
Standard treatment relies on immunosuppressive medication, and most patients manage the disease long-term this way under a rheumatologist’s care. Stem cell therapy is not a first-line treatment — it’s being explored specifically for patients whose disease hasn’t responded adequately to standard immunosuppression, and any decision to pursue it should follow, not bypass, a full rheumatological work-up. See Diagnosis for what that work-up involves, and Treatment for who is typically considered a candidate.
For broader context: see our Rheumatoid Arthritis page if joint-focused autoimmune symptoms are your primary concern, or the Orthopedic conditions hub for related autoimmune and inflammatory conditions we support.
What causes systemic lupus?
The exact cause of SLE isn’t fully understood, but research points to a combination of factors that together trigger the immune system to attack healthy tissue:
- Genetic predisposition — having a close relative with lupus or another autoimmune disease increases risk, though genetics alone don’t determine who develops it.
- Hormonal factors — SLE is diagnosed far more often in women than men, and flares are frequently linked to periods of elevated estrogen (such as during reproductive years or pregnancy), which is why hormonal influence is considered a significant contributing factor.
- Environmental triggers — infections, certain medications, and UV light exposure have all been associated with triggering or worsening lupus flares in genetically susceptible individuals.
- Immune system dysregulation — at a cellular level, the disease involves a breakdown in the immune system’s ability to distinguish the body’s own cells from foreign ones, leading to chronic inflammation and tissue damage.
Why finding your specific trigger pattern matters
Because lupus has no single cause, treatment planning depends heavily on which organs are affected and how active the disease currently is — not on a generic “lupus protocol.” This is why a comprehensive rheumatological evaluation (see Diagnosis) always precedes any discussion of stem cell therapy at Viezec: the same diagnosis of “SLE” can mean very different treatment priorities depending on whether kidney, skin, joint, or blood involvement predominates.
Related reading: Mechanism of Systemic Lupus Treatment for how MSCs are thought to interact with this immune dysregulation.
What are the symptoms of systemic lupus?
Symptoms vary significantly depending on which organs are involved and how active the disease is at a given time. Common symptoms include:
- Butterfly-shaped facial rash across the cheeks and nose bridge — one of the more recognizable signs of SLE
- Joint pain and swelling, often affecting multiple joints symmetrically
- Severe fatigue, frequently disproportionate to activity level
- Low-grade fever that comes and goes without an obvious infectious cause
- Hair loss (alopecia), often diffuse rather than in patches
- Anemia and blood-clotting abnormalities, detected through routine blood work
- Headaches, and in more severe cases, other neurological symptoms
- Extreme weakness and general malaise
Symptoms can range from barely noticeable to severely disabling, and they often flare and subside unpredictably — this variability is itself a hallmark of the disease rather than a sign that something else is going on.
When to seek evaluation
Because lupus symptoms overlap with several other conditions (rheumatoid arthritis, fibromyalgia, thyroid disorders), self-diagnosis based on symptoms alone isn’t reliable. If you’re experiencing several of the symptoms above — especially the facial rash combined with joint pain and fatigue — the appropriate next step is the diagnostic testing outlined below, not treatment planning.
Related reading: if joint symptoms are your dominant concern and facial rash/systemic involvement is absent, also review our Rheumatoid Arthritis and Fibromyalgia pages, since these conditions can present similarly.
How is systemic lupus diagnosed?
SLE is diagnosed through a combination of clinical evaluation and laboratory testing, typically overseen by a rheumatologist:
| Test | What it checks | Why it matters here |
|---|---|---|
| Antinuclear Antibody test (ANA) | Presence of autoantibodies that attack the body’s own cell nuclei | A positive ANA is present in the large majority of SLE patients, making it a key initial screening test |
| Anti-dsDNA and Anti-Sm antibody tests | More specific lupus-associated autoantibodies | Help confirm an SLE diagnosis and can correlate with disease activity, particularly kidney involvement |
| Complete blood count (CBC) | Anemia, low white cell count, low platelet count | Blood abnormalities are common in SLE and help assess disease severity |
| Complement levels (C3, C4) | Immune system protein levels | Often low during active lupus flares; useful for tracking disease activity over time |
| Urinalysis and kidney function tests | Protein or blood in urine, creatinine levels | Screens for lupus nephritis, one of the more serious organ complications of SLE |
| Skin or kidney biopsy (when indicated) | Tissue-level confirmation of lupus involvement | Used selectively, most often when kidney involvement is suspected |
Reports to share for a specialist review
- Antinuclear Antibody Test (ANA) results
- Anti-dsDNA / Anti-Sm antibody results, if performed
- Complete blood count (CBC)
- Urinalysis
- Any prior biopsy reports, if applicable
Our specialist team reviews existing reports before proposing any treatment plan — you can upload recent reports for a free case review rather than repeating tests unnecessarily.
Note on interpreting your own results: A positive ANA alone does not confirm SLE — it’s one piece of a broader clinical picture that includes symptoms, additional antibody tests, and organ involvement, assessed together by a rheumatologist. This is explained further under Who Is a Candidate in the Treatment section below.
Stem Cell Treatment for Systemic Lupus
Research into mesenchymal stem cells (MSCs) for systemic lupus erythematosus has produced encouraging early findings: MSCs are not recognized as foreign by the immune system, which makes them a relevant candidate for autoimmune conditions like SLE, where the goal is to calm — not further activate — immune activity. In studies to date, MSCs administered to SLE patients have been observed migrating toward areas of active inflammation, where they appear to support tissue repair. Researchers have reported meaningful improvement in study participants, alongside a favorable short-term safety profile, but caution that this remains investigational and that long-term outcomes are not yet established.
How does it work?
MSCs are being studied for three mechanisms relevant to lupus:
- Immune modulation — helping to rebalance an overactive immune response rather than suppressing it broadly (as conventional immunosuppressants do).
- Restoring immune tolerance — supporting the immune system’s ability to distinguish the body’s own tissue from a threat, addressing the core dysfunction in autoimmune disease.
- Tissue repair support — potentially aiding repair of organs damaged by chronic inflammation, such as kidney or skin tissue.
See Mechanism of Systemic Lupus Treatment below for more detail on how this connects to the broader physiological mechanism of stem cell therapy.
Who is a candidate?
Stem cell therapy for lupus is typically considered for patients who:
- Have a confirmed SLE diagnosis with moderate-to-severe or treatment-refractory disease activity
- Have not responded adequately to standard immunosuppressive medication
- Have been evaluated by a rheumatologist to confirm which organs are involved and how active the disease currently is
It is not proposed as a first-line treatment, and it is not offered in place of standard immunosuppressive therapy where that remains effective for a given patient — see the Treatment Disclaimer for how we frame this directly with patients.
Implantation and delivery methods
At Viezec, stem cells can be administered through several methods depending on the patient’s condition and treatment plan, including intravenous administration, intramuscular, subcutaneous, intra-arterial, and intrathecal (lumbar puncture) routes. Read more about delivery methods here.
What to expect: the treatment process
- Rheumatological and diagnostic review — existing reports (ANA, antibody panel, CBC, kidney function) are reviewed by our specialist team.
- Cell sourcing and processing — MSCs are prepared and quality-checked under laboratory conditions.
- Conditioning and administration — typically delivered via IV infusion in a controlled clinical setting, following any necessary pre-treatment conditioning.
- Monitoring — disease activity markers (complement levels, antibody titers, organ function) are tracked over subsequent weeks and months to assess response.
Frequently Asked Questions
What is stem cell treatment for systemic lupus?
Stem cell treatment involves using hematopoietic or mesenchymal stem cells to modulate the immune system, repair tissue damage, and reduce inflammation in patients with systemic lupus erythematosus (SLE).
Who is eligible for stem cell therapy in lupus?
Candidates typically include patients with severe or refractory lupus who have not responded adequately to standard immunosuppressive medications, under careful evaluation by specialists.
How is the therapy administered?
Stem cells are typically infused intravenously after conditioning therapy, in a controlled clinical setting. The procedure may vary depending on the type of stem cells and patient condition.
Is stem cell therapy safe for lupus patients?
When performed in certified centers with experienced medical teams, the therapy is generally safe. Possible side effects include temporary infection risk, fever, nausea, or mild immune reactions.
How long does it take to see results?
Clinical improvements may appear over several weeks to months, including reduced disease activity, improved organ function, and decreased reliance on immunosuppressive drugs.
How many sessions are typically required?
The number of sessions depends on patient-specific factors and disease severity. Most patients undergo a single infusion with follow-ups to monitor response and manage any complications.
Can stem cell therapy replace conventional lupus treatments?
Stem cell therapy is generally considered an adjunct or last-resort treatment. It complements conventional therapies but is not a guaranteed replacement for standard medications and lifestyle management.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or the appointment request form on our website. Our experts will evaluate your condition and create a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Systemic Lupus?
The cost of stem cell therapy for Systemic Lupus Erythematosus (SLE) varies depending on the patient’s disease severity, organ involvement (such as kidney, skin, or joints), stem cell source (autologous or allogeneic), number of sessions, and the hospital’s infrastructure. Costs also differ among countries and medical centers due to variations in healthcare systems and treatment standards. Below is a comparative overview to help understand the global pricing for lupus stem cell therapy.
Cost Comparison: Select Countries
The table below provides indicative cost ranges reported by medical centers and patients for a complete stem cell therapy protocol, including cell collection, lab processing, infusion, medical monitoring, and post-treatment care.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $25,000 – $40,000 | ₹20,70,000 – ₹33,10,000 |
| United Kingdom 🇬🇧 | $18,000 – $30,000 | ₹14,90,000 – ₹24,80,000 |
| Germany 🇩🇪 | $20,000 – $32,000 | ₹16,60,000 – ₹26,60,000 |
| Singapore 🇸🇬 | $15,000 – $25,000 | ₹12,40,000 – ₹20,60,000 |
While advanced nations such as the USA, UK, and Germany offer cutting-edge lupus stem cell programs, treatment costs are considerably higher due to complex healthcare infrastructure, hospital overheads, and insurance costs. In contrast, India provides equally advanced stem cell therapy at far more affordable prices, making it a preferred destination for international patients seeking high-quality and cost-effective regenerative treatment.
India’s lower treatment cost stems from reduced operational expenses, favorable exchange rates, and efficient healthcare delivery—not from compromised quality. Leading Indian hospitals feature internationally trained doctors, state-of-the-art laboratories, and GMP-certified stem cell facilities to ensure patient safety and positive therapeutic outcomes.
Why Choose Viezec?
Viezec helps connect patients with certified hospitals and regenerative medicine specialists experienced in treating autoimmune disorders like lupus. We ensure transparent pricing, ethical medical practices, and a personalized patient-care approach for every individual.
Get a Personalized Cost Estimate
Every lupus case is unique. Contact our medical experts to receive a customized quotation and treatment roadmap designed around your medical profile and recovery goals.
Improvements Seen After Stem Cell Therapy for Systemic Lupus
(This entire section replaces the current liver-disease content — “hepatic coma,” “vatical bleeding,” “abdominal dropsy” — which is incorrect for lupus and should be removed immediately regardless of any other changes.)
Current research on MSC therapy for SLE reports measurable changes in specific disease-activity and organ-function markers, in patients with moderate-to-severe or refractory disease. Individual results vary by organ involvement, disease duration, and baseline severity.
What improvement typically looks like
- Reduced overall disease activity, often measured using standardized indices such as the SLEDAI (SLE Disease Activity Index)
- Improved kidney function markers, in patients with lupus nephritis specifically
- Decreased autoantibody levels (such as anti-dsDNA), reflecting reduced immune overactivity
- Reduced reliance on high-dose immunosuppressive medication, in some patients, under close rheumatology supervision
- Improved fatigue and joint symptoms, reported in several small clinical studies
How improvement is monitored
| Marker | What it shows | Typically checked at |
|---|---|---|
| SLEDAI score | Overall disease activity | Baseline, 3, 6 months |
| Complement levels (C3, C4) | Immune activity trend | Baseline, 1, 3 months |
| Anti-dsDNA antibody titer | Autoantibody activity | Baseline, 3, 6 months |
| Kidney function (creatinine, urine protein) | Organ-specific response | Baseline, 3, 6 months |
What the research does not yet show
Most current evidence comes from small clinical cohorts and animal studies rather than large randomized controlled trials, and researchers consistently note that larger, longer-term studies are needed to establish standardized protocols. Stem cell therapy is not an established cure for SLE, and it does not replace standard immunosuppressive management where that remains effective.
Mechanism of Systemic Lupus Treatment
Stem cell treatment for SLE is performed using Mesenchymal Stem Cells (MSCs), typically supported by adjunct therapies that help boost treatment effectiveness and support recovery.
MSCs are believed to interact with the body’s natural healing processes, potentially accelerating tissue regeneration in areas affected by chronic inflammation. In the context of lupus specifically, this translates to two parallel effects under research: a reduction in the inflammatory activity driving flares, and support for repair of tissue already damaged by the disease (particularly relevant in lupus nephritis, where kidney tissue is affected).
Read more about the physiological mechanism here, or see How Stem Cell Therapy Works for the general process across conditions.
Our Promise
Viezec is committed to transparent, evidence-based regenerative medicine care for lupus patients — not overstated claims about an investigational treatment. In practice, this means:
- No cure claims. Stem cell therapy for lupus is offered as a researched, adjunct option for refractory disease — never marketed as a cure or guaranteed outcome.
- Rheumatology-first evaluation. No stem cell protocol is proposed without a completed rheumatological work-up confirming disease activity, organ involvement, and prior treatment response.
- Named, credentialed medical oversight. Every treatment plan is reviewed by a qualified rheumatology/regenerative medicine specialist.
- Regulatory transparency. As stated in your own footer disclaimer, stem cell interventions beyond approved uses are investigational in India and available only within regulated research settings — this same language should appear here in the body content, not only in the footer, so it’s visible to readers before they scroll past the treatment details.
- Accredited facilities. Our facilities hold NABH accreditation and NABL accreditation.
- Written, itemized cost estimates provided after medical evaluation, before any commitment.
- Location and access clarity. Our facility is based in New Delhi, India, with support for international patients including visa assistance and remote follow-up monitoring.
Read more about why patients choose India for stem cell therapy.
Testimonials
Priya S. – Delhi, India – January 2020 – ⭐⭐⭐⭐☆
“I had severe joint pain and fatigue from lupus. After Viezec’s stem cell therapy, my energy improved, and my flare-ups reduced.”
Hannah R. – London, UK – July 2020 – ⭐⭐⭐⭐⭐
“Lupus left me exhausted and in constant pain. Post-treatment at Viezec, my symptoms eased, and I feel more active and hopeful.”
Ahmed K. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“My wife suffered frequent lupus flares. After stem cell therapy, her joint swelling reduced, and her mobility has improved.”
Isabella M. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“Stem cell therapy at Viezec gave me relief from skin rashes and fatigue. My lupus is more stable now, and I can enjoy daily life.”
Youssef A. – Casablanca, Morocco – August 2021 – ⭐⭐⭐⭐☆
“I was dependent on medication for lupus. Thanks to Viezec’s treatment, my reliance decreased, and my health feels more balanced.”
Emily J. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“Chronic pain made lupus unbearable. After Viezec’s stem cell therapy, my pain reduced, and my sleep has improved significantly.”
Omar H. – Amman, Jordan – September 2022 – ⭐⭐⭐⭐☆
“Lupus had weakened my immune system. After therapy at Viezec, I feel stronger, and infections have become less frequent.”
Maria G. – Madrid, Spain – April 2023 – ⭐⭐⭐⭐⭐
“My lupus symptoms were worsening every year. Viezec’s stem cell therapy stabilized my condition and gave me back my confidence.”
George T. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“Severe fatigue and pain ruled my days. After treatment at Viezec, my energy returned, and I can enjoy family activities again.”
Fatima N. – Istanbul, Turkey – June 2025 – ⭐⭐⭐⭐⭐
“I feared lupus would take away my independence. Thanks to Viezec’s stem cell therapy, I feel healthier, more active, and positive about my future.”
Treatment Results for Systemic Lupus at Viezec
Systemic lupus is a chronic autoimmune disease that can cause inflammation across connective tissues, joints, skin, kidneys, lungs, and the nervous system, varying significantly between patients depending on which organs are involved.
Mesenchymal stem cells are being studied for their anti-inflammatory properties, which may help calm the immune overactivity driving lupus flares and support regeneration of affected tissue. In studies and case reports to date, some patients have reported meaningful improvement in daily functioning, reduced pain, and greater activity levels — though, as with all sections on this page, these are individual outcomes rather than guaranteed results.
Treatment Disclaimer
Is stem cell therapy a guaranteed treatment for lupus?
No. Stem cell therapy for systemic lupus is experimental and may not work for every patient. At any stage of evaluation, treatment may be declined, or the proposed protocol may change, based on your specific health condition. Viezec makes no guarantees or claims of cure, and outcomes vary between patients even with a similar diagnosis. We do not use embryonic or fetal cells in any treatment.
What does the current evidence show?
Research into MSC therapy for SLE is still developing. Some studies report reduced disease activity and improved organ function in select patients; others show more limited or inconsistent results. This remains an active research area, not an established standard of care recognized by major rheumatology bodies at this time.
Who is this treatment intended for?
Primarily patients with moderate-to-severe or treatment-refractory lupus who have not responded adequately to standard immunosuppressive therapy, following a complete rheumatological evaluation. It is not offered as a first-line treatment.
Who oversees treatment decisions?
All treatment plans are reviewed by our specialist team following evaluation of your antibody panel, complement levels, and organ function tests. No protocol is recommended without this review.
Is this treatment regulated?
Stem cell-based interventions beyond approved uses are investigational in India and available only within regulated clinical research settings. We encourage every patient to ask directly which framework applies to their case and to independently verify facility accreditation.
Where can I get a specific answer for my case?
Book a consultation with our specialist team to review your reports and discuss candidacy for your specific case.
Scientific References
The following peer-reviewed studies, clinical guidelines, and scientific publications support current evidence on systemic lupus erythematosus (SLE), including stem cell therapy research and treatment recommendations.
Conclusion
Stem cell therapy offers a researched avenue for patients with systemic lupus whose disease hasn’t responded adequately to standard treatment, by targeting immune dysregulation and supporting tissue repair. At Viezec, this is always positioned alongside — not instead of — rheumatology-led care, following a full diagnostic evaluation. Our specialist team combines regenerative medicine expertise with transparent, evidence-based communication about what current research does and doesn’t show. To find out whether your specific case makes you a candidate, upload your reports for a free specialist review.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
